Tempest Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.About TPST
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
CEOStephen R. Brady
CEOStephen R. Brady
Employees25
Employees25
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees25
Employees25
TPST Key Statistics
Market cap12.96M
Market cap12.96M
Price-Earnings ratio-0.26
Price-Earnings ratio-0.26
Dividend yield—
Dividend yield—
Average volume65.53K
Average volume65.53K
High today$2.69
High today$2.69
Low today$2.58
Low today$2.58
Open price$2.59
Open price$2.59
Volume21.17K
Volume21.17K
52 Week high$13.13
52 Week high$13.13
52 Week low$2.40
52 Week low$2.40
Stock Snapshot
The current Tempest Therapeutics(TPST) stock price is $2.61, with a market capitalization of 12.96M. The stock trades at a price-to-earnings (P/E) ratio of -0.26.
On 2026-01-21, Tempest Therapeutics(TPST) stock traded between a low of $2.58 and a high of $2.69. Shares are currently priced at $2.61, which is +1.1% above the low and -2.8% below the high.
Tempest Therapeutics(TPST) shares are trading with a volume of 21.17K, against a daily average of 65.53K.
During the past year, Tempest Therapeutics(TPST) stock moved between $2.40 at its lowest and $13.13 at its peak.
During the past year, Tempest Therapeutics(TPST) stock moved between $2.40 at its lowest and $13.13 at its peak.
People also own
Based on the portfolios of people who own TPST. This list is generated using Robinhood data, and it’s not a recommendation.